{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:32:06Z","timestamp":1793716326287,"version":"4.6.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Burns"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.burns.2021.02.013","type":"journal-article","created":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T11:57:14Z","timestamp":1614167834000},"page":"987-998","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["The safety and efficacy of intralesional triamcinolone acetonide for keloids and hypertrophic scars: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8509-5667","authenticated-orcid":false,"given":"ZhiHao","family":"Zhuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3538-1881","authenticated-orcid":false,"given":"YunTong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XuJin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.burns.2021.02.013_bib0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19030711","article-title":"Recent understandings of biology, prophylaxis and treatment strategies for hypertrophic scars and keloids","volume":"19","author":"Lee","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.burns.2021.02.013_bib0010","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/wrr.12432","article-title":"Current concepts related to hypertrophic scarring in burn injuries","volume":"24","author":"Chiang","year":"2016","journal-title":"Wound Repair Regen"},{"issue":"5","key":"10.1016\/j.burns.2021.02.013_bib0015","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1742-481X.2012.01118.x","article-title":"Are keloid and hypertrophic scar different forms of the same disorder? A fibroproliferative skin disorder hypothesis based on keloid findings","volume":"11","author":"Huang","year":"2014","journal-title":"Int Wound J"},{"key":"10.1016\/j.burns.2021.02.013_bib0020","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mehy.2016.09.024","article-title":"Endothelial dysfunction may play a key role in keloid and hypertrophic scar pathogenesis \u2014 keloids and hypertrophic scars may be vascular disorders","volume":"96","author":"Ogawa","year":"2016","journal-title":"Med Hypotheses"},{"issue":"3","key":"10.1016\/j.burns.2021.02.013_bib0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18030606","article-title":"Keloid and hypertrophic scars are the result of chronic inflammation in the reticular dermis","volume":"18","author":"Ogawa","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.burns.2021.02.013_bib0030","first-page":"78","article-title":"Intralesional injections of triamcinolone acetonide: a therapy for dermatoses","volume":"8","author":"Hollander","year":"1961","journal-title":"Antibiotic Med Clin Ther (New York)"},{"issue":"4","key":"10.1016\/j.burns.2021.02.013_bib0035","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jamcollsurg.2007.11.022","article-title":"Scar treatments: preclinical and clinical studies","volume":"206","author":"Reish","year":"2008","journal-title":"J Am Coll Surg"},{"issue":"1\u20132","key":"10.1016\/j.burns.2021.02.013_bib0040","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2119\/molmed.2009.00153","article-title":"Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies","volume":"17","author":"Gauglitz","year":"2011","journal-title":"Mol Med (Cambridge, Mass)"},{"issue":"1","key":"10.1016\/j.burns.2021.02.013_bib0045","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4103\/0378-6323.74968","article-title":"Standard guidelines of care: keloids and hypertrophic scars","volume":"77","author":"Gupta","year":"2011","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"10","key":"10.1016\/j.burns.2021.02.013_bib0050","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/archotol.1990.01870100053011","article-title":"Intralesional interferon gamma treatment for keloids and hypertrophic scars","volume":"116","author":"Larrabee","year":"1990","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"5","key":"10.1016\/j.burns.2021.02.013_bib0055","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00403-013-1328-7","article-title":"Identification of steroid sensitive responders versus non-responders in the treatment of keloid disease","volume":"305","author":"Ud-Din","year":"2013","journal-title":"Arch Dermatol Res"},{"issue":"4","key":"10.1016\/j.burns.2021.02.013_bib0060","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.burns.2021.02.013_bib0065","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1097\/01.PRS.0000122207.28773.56","article-title":"The patient and observer scar assessment scale: a reliable and feasible tool for scar evaluation","volume":"113","author":"Draaijers","year":"2004","journal-title":"Plast Reconstr Surg"},{"issue":"11","key":"10.1016\/j.burns.2021.02.013_bib0070","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1089\/wound.2017.0741","article-title":"Comparison of intralesional triamcinolone acetonide, 5-Fluorouracil, and their combination for the treatment of keloids","volume":"6","author":"Srivastava","year":"2017","journal-title":"Adv Wound Care"},{"issue":"1","key":"10.1016\/j.burns.2021.02.013_bib0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1089\/wound.2018.0798","article-title":"Comparison of fractional CO2 laser, verapamil, and triamcinolone for the treatment of keloid","volume":"8","author":"Srivastava","year":"2018","journal-title":"Adv Wound Care"},{"issue":"2","key":"10.1016\/j.burns.2021.02.013_bib0080","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/jocd.12134","article-title":"Intralesional botulinum toxin type A equally effective and better tolerated than intralesional steroid in the treatment of keloids: a randomized controlled trial","volume":"14","author":"Shaarawy","year":"2015","journal-title":"J Cosmet Dermatol"},{"issue":"2","key":"10.1016\/j.burns.2021.02.013_bib0085","first-page":"114","article-title":"Comparison of efficacy of intralesional 5-fluorouracil plus triamcinolone acetonide versus intralesional triamcinolone acetonide in the treatment of keloids","volume":"27","author":"Saleem","year":"2017","journal-title":"J Pakistan Assoc Dermatologists"},{"issue":"1","key":"10.1016\/j.burns.2021.02.013_bib0090","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1524-4725.2011.02137.x","article-title":"Comparison of the efficacy of intralesional triamcinolone acetonide and 5-fluorouracil tattooing for the treatment of keloids","volume":"38","author":"Sadeghinia","year":"2012","journal-title":"Dermatol Surg"},{"issue":"1","key":"10.1016\/j.burns.2021.02.013_bib0095","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/jocd.12132","article-title":"The treatment of keloids and hypertrophic scars with intralesional bleomycin in skin of color","volume":"14","author":"Payapvipapong","year":"2015","journal-title":"J Cosmet Dermatol"},{"issue":"4","key":"10.1016\/j.burns.2021.02.013_bib0100","doi-asserted-by":"crossref","first-page":"343","DOI":"10.4103\/0378-6323.42899","article-title":"Comparison of intralesional verapamil with intralesional triamcinolone in the treatment of hypertrophic scars and keloids","volume":"74","author":"Margaret Shanthi","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"9","key":"10.1016\/j.burns.2021.02.013_bib0105","first-page":"1003","article-title":"Intralesional triamcinolone alone and in combination with 5-fluorouracil for the treatment of keloid and hypertrophic scars","volume":"64","author":"Khan","year":"2014","journal-title":"J Pak Med Assoc"},{"issue":"5","key":"10.1016\/j.burns.2021.02.013_bib0110","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13036","article-title":"Comparison of the efficacy of intralesional bleomycin versus intralesional triamcinolone acetonide in the treatment of keloids","volume":"32","author":"Khan","year":"2019","journal-title":"Dermatol Ther"},{"issue":"1","key":"10.1016\/j.burns.2021.02.013_bib0115","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.burns.2018.08.011","article-title":"Comparison of efficacy and safety of intralesional triamcinolone and combination of triamcinolone with 5-fluorouracil in the treatment of keloids and hypertrophic scars: randomised control trial","volume":"45","author":"Khalid","year":"2018","journal-title":"Burns"},{"key":"10.1016\/j.burns.2021.02.013_bib0120","article-title":"Treatment of keloid scars with intralesional triamcinolone and 5-fluorouracil injections \u2014 a randomized controlled trial","author":"Hietanen","year":"2018","journal-title":"J Plast Reconstr Aesthetic Surg"},{"key":"10.1016\/j.burns.2021.02.013_bib0125","first-page":"1","article-title":"Combined intralesional triamcinolone acetonide and platelet rich plasma versus intralesional triamcinolone acetonide alone in treatment of keloids","author":"Hewedy","year":"2020","journal-title":"J Dermatolog Treat"},{"issue":"7","key":"10.1016\/j.burns.2021.02.013_bib0130","first-page":"907","article-title":"New combination of triamcinolone, 5-Fluorouracil, and pulsed-dye laser for treatment of keloid and hypertrophic scars","volume":"32","author":"Asilian","year":"2006","journal-title":"Dermatol Surg"},{"issue":"4","key":"10.1016\/j.burns.2021.02.013_bib0135","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.burns.2013.09.029","article-title":"Comparative efficacy of intralesional verapamil hydrochloride and triamcinolone acetonide in hypertrophic scars and keloids","volume":"40","author":"Ahuja","year":"2014","journal-title":"Burns"},{"issue":"10","key":"10.1016\/j.burns.2021.02.013_bib0140","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1111\/ijd.14069","article-title":"A comparative study of various modalities in the treatment of keloids","volume":"57","author":"Aggarwal","year":"2018","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.burns.2021.02.013_bib0145","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00266-019-01518-y","article-title":"Comparative efficacy and safety of common therapies in keloids and hypertrophic scars: a systematic review and meta-analysis","volume":"44","author":"Bao","year":"2020","journal-title":"Aesthetic Plast Surg"},{"key":"10.1016\/j.burns.2021.02.013_bib0150","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fmed.2016.00071","article-title":"The efficacy of triamcinolone acetonide in keloid treatment: a systematic review and meta-analysis","volume":"3","author":"Wong","year":"2016","journal-title":"Front Med"},{"issue":"3","key":"10.1016\/j.burns.2021.02.013_bib0155","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/iwj.12629","article-title":"Efficacy and safety of triamcinolone acetonide alone and in combination with 5-fluorouracil for treating hypertrophic scars and keloids: a systematic review and meta-analysis","volume":"14","author":"Ren","year":"2017","journal-title":"Int Wound J"},{"issue":"3","key":"10.1016\/j.burns.2021.02.013_bib0160","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/PRS.0000000000005323","article-title":"Treatment of keloid scars with botulinum toxin type a versus triamcinolone in an athymic nude mouse model","volume":"143","author":"Fanous","year":"2019","journal-title":"Plast Reconstr Surg"},{"issue":"3","key":"10.1016\/j.burns.2021.02.013_bib0165","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4103\/0378-6323.173586","article-title":"Assessment of intralesional injection of botulinum toxin type A injection for hypertrophic scars","volume":"82","author":"Elhefnawy","year":"2016","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"3","key":"10.1016\/j.burns.2021.02.013_bib0170","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00266-009-9334-z","article-title":"Treatment of hypertrophic scars with intralesional botulinum toxin type A injections: a preliminary report","volume":"33","author":"Xiao","year":"2009","journal-title":"Aesthetic Plast Surg"},{"issue":"12","key":"10.1016\/j.burns.2021.02.013_bib0175","first-page":"791","article-title":"[Treatment of keloid with intralesional bleomycin]","volume":"123","author":"Bodokh","year":"1996","journal-title":"Ann Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.burns.2021.02.013_bib0180","first-page":"23","article-title":"Bleomycin in the treatment of keloids and hypertrophic scars by multiple needle punctures","volume":"27","author":"Espa\u00f1a","year":"2001","journal-title":"Dermatol Surg"},{"issue":"6","key":"10.1016\/j.burns.2021.02.013_bib0185","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.burns.2013.01.020","article-title":"Objective evaluation of the effect of autologous platelet concentrate on post-operative scarring in deep burns","volume":"39","author":"Klosov\u00e1","year":"2013","journal-title":"Burns"}],"container-title":["Burns"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417921000498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417921000498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T08:16:05Z","timestamp":1759652165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305417921000498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0305417921000498"],"URL":"https:\/\/doi.org\/10.1016\/j.burns.2021.02.013","relation":{},"ISSN":["0305-4179"],"issn-type":[{"value":"0305-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The safety and efficacy of intralesional triamcinolone acetonide for keloids and hypertrophic scars: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Burns","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.burns.2021.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd and ISBI. All rights reserved.","name":"copyright","label":"Copyright"}]}}